Ideaya Biosciences Stock Probability of Future Stock Price Finishing Under 24.83
| IDYA Stock | USD 26.54 0.25 0.93% |
Ideaya |
Ideaya Biosciences Target Price Odds to finish below 24.83
The tendency of Ideaya Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 24.83 or more in 90 days |
| 26.54 | 90 days | 24.83 | roughly 2.98 |
Based on a normal probability distribution, the odds of Ideaya Biosciences to drop to $ 24.83 or more in 90 days from now is roughly 2.98 (This Ideaya Biosciences probability density function shows the probability of Ideaya Stock to fall within a particular range of prices over 90 days) . Probability of Ideaya Biosciences price to stay between $ 24.83 and its current price of $26.54 at the end of the 90-day period is nearly 4.4 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.65 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ideaya Biosciences will likely underperform. Additionally Ideaya Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Ideaya Biosciences Price Density |
| Price |
Predictive Modules for Ideaya Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ideaya Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ideaya Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ideaya Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ideaya Biosciences is not an exception. The market had few large corrections towards the Ideaya Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ideaya Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ideaya Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.71 | |
β | Beta against Dow Jones | 1.65 | |
σ | Overall volatility | 3.94 | |
Ir | Information ratio | -0.22 |
Ideaya Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ideaya Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ideaya Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ideaya Biosciences generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 23.39 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (38.6 M). | |
| Ideaya Biosciences currently holds about 268.62 M in cash with (115.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.83. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer |
Ideaya Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ideaya Stock often depends not only on the future outlook of the current and potential Ideaya Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ideaya Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.5 M | |
| Cash And Short Term Investments | 525.1 M |
Ideaya Biosciences Technical Analysis
Ideaya Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Ideaya Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ideaya Biosciences. In general, you should focus on analyzing Ideaya Stock price patterns and their correlations with different microeconomic environments and drivers.
Ideaya Biosciences Predictive Forecast Models
Ideaya Biosciences' time-series forecasting models is one of many Ideaya Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ideaya Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ideaya Biosciences
Checking the ongoing alerts about Ideaya Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ideaya Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ideaya Biosciences generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 23.39 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (38.6 M). | |
| Ideaya Biosciences currently holds about 268.62 M in cash with (115.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.83. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer |
Check out Ideaya Biosciences Backtesting, Ideaya Biosciences Valuation, Ideaya Biosciences Correlation, Ideaya Biosciences Hype Analysis, Ideaya Biosciences Volatility, Ideaya Biosciences History as well as Ideaya Biosciences Performance. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 0.051 | Quarterly Revenue Growth (0.03) | Return On Assets (0.16) | Return On Equity (0.21) |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.